[ Price : $8.95]
A Center for Medicine in the Public Interest opinion column calls on FDA to more aggressively recruit and use advisory committee t...[ Price : $8.95]
A survey of 37 biotech executives shows FDA obstacles are sending more first-in-human trials overseas.[ Price : $8.95]
CDER associate Center director for strategic initiatives Theresa Mullin retires after 28 years at the agency.[ Price : $8.95]
FDA posts an updated guidance outlining procedures for formal meetings between the agency and sponsors or applicants developing or...[ Price : $8.95]
FDA officials detailing the agencys new expedited IND pilot program say a central feature will be a rolling pre-IND submission pro...[ Price : $8.95]
Eli Lilly files six new lawsuits against U.S. entities it alleges are selling illegal, unapproved retatrutide products.[ Price : $8.95]
An updated Class 1 recall notice says Hamilton Medical is recommending that certain coaxial breathing circuit sets used with HAMIL...[ Price : $8.95]
FDA accepts for priority review a Belite Bio NDA for tinlarebant for treating Stargardt Disease Type 1.